CIK 0001582554 · Non-accelerated filer<br>Smaller reporting company
Matinas BioPharma Holdings, Inc.
Sign in to watch- Ticker
- MTNB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463011414
- Phone
- 908-484-8805
- Business address
- 1545 ROUTE 206 SOUTH, SUITE 302, BEDMINSTER, NJ, 07921
- 4 Open-market buy Director bought 15,000 shares at $0.80 ($12,000)
- 4 Open-market buy President and CEO bought 12,487 shares at $0.80 ($9,980)
- 4 Open-market buy Director bought 20,000 shares at $0.80 ($15,998)
- 4 Open-market buy Director bought 15,000 shares at $0.82 ($12,300)
- 4 Open-market buy Director bought 20,000 shares at $0.89 ($17,800)
- 4 Open-market buy Director bought 80,000 shares at $0.94 ($75,200)
- 4 Open-market buy Director bought 150,000 shares at $0.95 ($142,500)
- 4 Open-market buy Director bought 100,000 shares at $0.95 ($95,250)
- 4 Open-market buy Director bought 25,000 shares at $0.96 ($24,115)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Grant or award Director acquired 14,565 shares (grant or award)
- 4 Grant or award Director acquired 22,019 shares (grant or award)
- 4 Grant or award Director acquired 17,202 shares (grant or award)
- 4/A Grant or award Director acquired 12,201 shares (grant or award)
- 8-K Event Results of operations
- 10-K Report Annual Report
- SC 13G Stake Amended Statement of Ownership
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Regulation FD disclosure · Other events
Page 18 of 29 · 576 filings